The role of PAR1 across different cancers, where it acts variably as an oncogene in breast and prostate cancers and is involved in malignancy processes like angiogenesis, tumor invasiveness, and metastasis, is well documented [[54], [55], [56]]. The gene discussed is F2R; the disease is prostate carcinoma.